Multisystemic Effects of Elexacaftor–Tezacaftor–Ivacaftor in Adults with Cystic Fibrosis and Advanced Lung Disease

Pierre-Régis Burgel, Jean-Louis Paillasseur, Isabelle Durieu, Martine Reynaud-Gaubert, Rebecca Hamidfar, Marlène Murris-Espin, Isabelle Danner-Boucher, Raphaël Chiron, Sylvie Leroy, Benoit Douvry, Dominique Grenet, Laurent Mely, Sophie Ramel, Sylvie Montcouquiol, Espérie Burnet, El Hassane Ouaalaya, Philippe Sogni, Jennifer Da Silva, Clémence Martin

Open source

DOI: 10.1513/annalsats.202312-1065oc
Published: 2024-07-01
Container: Annals of the American Thoracic Society
Publisher: Oxford University Press (OUP)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1513/annalsats.202312-1065oc,
  title = {Multisystemic Effects of Elexacaftor–Tezacaftor–Ivacaftor in Adults with Cystic Fibrosis and Advanced Lung Disease},
  author = {Pierre-Régis Burgel and Jean-Louis Paillasseur and Isabelle Durieu and Martine Reynaud-Gaubert and Rebecca Hamidfar and Marlène Murris-Espin and Isabelle Danner-Boucher and Raphaël Chiron and Sylvie Leroy and Benoit Douvry and Dominique Grenet and Laurent Mely and Sophie Ramel and Sylvie Montcouquiol and Espérie Burnet and El Hassane Ouaalaya and Philippe Sogni and Jennifer Da Silva and Clémence Martin},
  year = {2024},
  journal = {Annals of the American Thoracic Society},
  doi = {10.1513/annalsats.202312-1065oc},
  url = {https://doi.org/10.1513/annalsats.202312-1065oc}
}

RIS

TY  - JOUR
TI  - Multisystemic Effects of Elexacaftor–Tezacaftor–Ivacaftor in Adults with Cystic Fibrosis and Advanced Lung Disease
AU  - Pierre-Régis Burgel
AU  - Jean-Louis Paillasseur
AU  - Isabelle Durieu
AU  - Martine Reynaud-Gaubert
AU  - Rebecca Hamidfar
AU  - Marlène Murris-Espin
AU  - Isabelle Danner-Boucher
AU  - Raphaël Chiron
AU  - Sylvie Leroy
AU  - Benoit Douvry
AU  - Dominique Grenet
AU  - Laurent Mely
AU  - Sophie Ramel
AU  - Sylvie Montcouquiol
AU  - Espérie Burnet
AU  - El Hassane Ouaalaya
AU  - Philippe Sogni
AU  - Jennifer Da Silva
AU  - Clémence Martin
PY  - 2024
JO  - Annals of the American Thoracic Society
DO  - 10.1513/annalsats.202312-1065oc
UR  - https://doi.org/10.1513/annalsats.202312-1065oc
ER  -

APA

Burgel, P., Paillasseur, J., Durieu, I., Reynaud-Gaubert, M., Hamidfar, R., Murris-Espin, M., Danner-Boucher, I., Chiron, R., Leroy, S., Douvry, B., Grenet, D., Mely, L., Ramel, S., Montcouquiol, S., Burnet, E., Ouaalaya, E. H., Sogni, P., Silva, J. D., & Martin, C. (2024). Multisystemic Effects of Elexacaftor–Tezacaftor–Ivacaftor in Adults with Cystic Fibrosis and Advanced Lung Disease. Annals of the American Thoracic Society. https://doi.org/10.1513/annalsats.202312-1065oc

Source records

crossref · retrieved 2026-09-25T22:06:38.456Z